In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
ARQ 092（一种变构 AKT 抑制剂）对源自患有 PIK3CA 相关过度生长谱 (PROS) 的患者原代成纤维细胞的体外疗效
期刊:Neurogenetics
影响因子:1.6
doi:10.1007/s10048-018-0540-1
C Ranieri, S Di Tommaso, D C Loconte, V Grossi, P Sanese, R Bagnulo, F C Susca, G Forte, A Peserico, A De Luisi, A Bartuli, A Selicorni, D Melis, M Lerone, A D Praticò, G Abbadessa, Y Yu, B Schwartz, Martino Ruggieri, Cristiano Simone, Nicoletta Resta
